Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02434627 · ClinicalTrials.gov registry record · Phase 1
Sodium Nitrate for Muscular Dystrophy
A Phase 1 study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT02434627 is a Phase 1 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 5 participants.
The verdict
NCT02434627, a Phase 1 study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators' previous work in males with Becker Muscular Dystrophy shows that functional sympatholysis is restored by acute inorganic nitrate supplementation. This was translated from work using the mdx mouse model of dystrophinopathy. Recent work has shown that there is a frank improvement in grip strength when mdx mice are treated with an inorganic Nitric Oxide (NO) donor. The purpose of this study is to determine if chronic treatment with an inorganic NO donor can benefit patients with muscular dystrophy beyond blood flow regulation.
Interventions
- DRUG Sodium Nitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-06 |
| Est. Completion | 2018-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02434627
The ClinicalTrials.gov registry entry for NCT02434627 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sodium Nitrate is the first listed.
NCT02434627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02434627 about?
NCT02434627 is a clinical study titled "Sodium Nitrate for Muscular Dystrophy". The investigators' previous work in males with Becker Muscular Dystrophy shows that functional sympatholysis is restored by acute inorganic nitrate supplementation. This was translated from work using the mdx mouse model of dystrophinopathy. Recent work has shown that there is a frank improvement in...
What is the current status of trial NCT02434627?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2015-06. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02434627?
The interventions under investigation include: Sodium Nitrate (DRUG).
Who is sponsoring clinical trial NCT02434627?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.